Every moment matters when facing a cancer diagnosis. Leica Biosystems empowers healthcare professionals to quickly and reliably deliver accurate diagnoses, transforming anxiety into answers for millions of people worldwide.
Our innovation is fueled by R&D investment, driven by customer insight, and proven by a robust patent portfolio. We strive to realize our purpose, enabling clinicians to efficiently provide patients a highly confident diagnosis within 24-hours from biopsy.
Continuous improvement drives our global experts. We know real breakthroughs come from inclusive teams that think big, learn from diverse perspectives, and focus on outcomes that matter.
“The Leica Biosystems team understand that standardisation and interoperability are vital for the adoption of digital pathology and development of artificial intelligence. We value their methodical and practical approach, helping pathology to become increasingly digital and advancing our work at the UK National Pathology Imaging Co-operative program.”
"Leica Biosystems products are reliable and high quality, and the company is realistic about what's required to transform traditional pathology to a digital, connected practice. I know I can count on them and trust they will be there to support me now and well into the future."
Thanks to our partnership with Leica, we have access to instruments of the highest caliber. The whole approach is about the quality, traceability, and connectivity…It's a base to work on innovation and development relying on the know-how of the pathologist. We also want to develop other technologies associated with this basis. So, it can be digital pathology technologies based on artificial intelligence.
"Thank you for the fine connective system from Leica Biosystems, the systems well match the pathology works and studies at Kurume University. Recently we have tried to do case studies with hematologists and hematopathologists from over 20 hospitals and universities, using the virtual slide systems. The virtual slides work well in the web meetings, allowing good communication with the hematologists and hematopathologists. We are looking forward to collaborating with Leica Biosystems with Digital Pathology in the future."
150+ years by your side. Discover and diagnose with confidence using trusted solutions for every step of slide preparation.
Advanced staining instruments and optimized reagents proven to deliver high-quality slides.
Discover why thousands of organizations worldwide implement Aperio solutions for connected digital pathology.
Explore our Research Solutions
Our purpose is to enable researchers to accelerate their journey, transforming scientific exploration into translational outcomes.
Our goal is to shape the future with novel technologies that inspire every researcher’s exploration of biology.
Upcoming Webinar
Save Your Spot Today
Date: January 26, 2023
Time: 8:00AM (PST), 11:00 PM (EST), 5:00 PM (CET)
Register now to hear Nicholas Confuorto, Sr. Director of Global Field Applications, Nanostring Technologies, talk about how they have recently developed a fully automated sample processing RNA workflow for use with the BOND RX fully automated research stainer from Leica Biosystems.
For Research Use Only
Join Leica Biosystems at Medlab Middle East 6th – 9th February 2023
Digital pathology slide scanners play a key role in screening and analyzing tissue sections prepared by histological procedures. Scanning of slides digitally enables laboratories to accurately capture and process more slides than ever before.
Come and see us at this year’s Medlab Middle East at Leica Biosystems stand # Z2.K29.
For In Vitro Diagnostic Use
Tissue Processors
Microtomes
Cryostats
H&E Slide Stainers and Coverslippers
IHC & ISH Instruments
BOND RX Multiplex IHC Stainer
BOND-III Automated IHC Stainer
BOND-MAX IHC & ISH Stainer
